Selected article for: "appropriate treatment and mortality rate"
Author: Kermani-Alghoraishi, Mohammad
Title: A Review of Coronary Artery Thrombosis: A New Challenging Finding in COVID-19 Patients and ST-elevation Myocardial Infarction
  • Cord-id: r6t16mzw
  • Document date: 2020_11_2
    • ID: r6t16mzw
    Snippet: As the COVID-19 pandemic continues, more information on the non-respiratory effects of the coronavirus is obtained. Cardiovascular complications, especially acute coronary syndromes, are rare. However, they prove to be effective factors in the mortality rate of COVID-19 subjects. Acute ST-elevation myocardial infarction with a special angiographic pattern in the form of extensive and multi-vessel thrombosis, regardless of atherosclerotic plaques, has posed a new therapeutic challenge. This has b
    Document: As the COVID-19 pandemic continues, more information on the non-respiratory effects of the coronavirus is obtained. Cardiovascular complications, especially acute coronary syndromes, are rare. However, they prove to be effective factors in the mortality rate of COVID-19 subjects. Acute ST-elevation myocardial infarction with a special angiographic pattern in the form of extensive and multi-vessel thrombosis, regardless of atherosclerotic plaques, has posed a new therapeutic challenge. This has been associated with an increase in the incidence of stent thrombosis. Hypercoagulation, due to severe inflammation, is the main pathology of this phenomenon. Technically, percutaneous coronary intervention with aspiration thrombectomy and injectable antiplatelet are the mainstay of treatment for these patients. In addition, it is vital that appropriate antiplatelet and ischemia treatment after the intervention be taken into account.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute myocardial injury: 1
    • acs acute coronary syndrome and acute acvc cardiovascular care association: 1, 2
    • acs acute coronary syndrome and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acs acute coronary syndrome and acute dissection: 1
    • acs acute coronary syndrome and acute myocardial injury: 1, 2, 3
    • acs acute coronary syndrome and acvc cardiovascular care association: 1, 2
    • acs acute coronary syndrome and long term follow: 1
    • acs patient and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7
    • acute acvc cardiovascular care association and acvc cardiovascular care association: 1, 2
    • acute coronary syndrome and acvc cardiovascular care association: 1, 2
    • acute coronary syndrome and long term follow: 1, 2, 3, 4, 5
    • acute coronary syndrome and lopinavir ritonavir: 1, 2
    • acute dissection and long term follow: 1
    • acute myocardial injury and long term follow: 1, 2
    • acute myocardial injury and lopinavir ritonavir: 1
    • acute range and long term follow: 1
    • acute range and lopinavir ritonavir: 1, 2
    • long term follow and lopinavir ritonavir: 1